The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Extended endocrine therapy after 5 years of adjuvant LHRH-agonist in premenopausal patients with node-positive hormone receptor (HR)-positive early breast cancer.
 
Carmine Valenza
No Relationships to Disclose
 
Yue Zheng
No Relationships to Disclose
 
Monica Milano
No Relationships to Disclose
 
Elisa Giordano
No Relationships to Disclose
 
Lorenzo Guidi
No Relationships to Disclose
 
Pier Paolo Maria Berton Giachetti
No Relationships to Disclose
 
Laura Boldrini
No Relationships to Disclose
 
Grazia Castellano
No Relationships to Disclose
 
Jalissa Katrini
No Relationships to Disclose
 
Bianca Malagutti
No Relationships to Disclose
 
Gabriele Antonarelli
Travel, Accommodations, Expenses - MEDSIR
 
Fabio Conforti
No Relationships to Disclose
 
Eleonora Pagan
No Relationships to Disclose
 
Vincenzo Bagnardi
No Relationships to Disclose
 
Gregory Kirkner
No Relationships to Disclose
 
Dario Trapani
No Relationships to Disclose
 
Kate Dibble
Stock and Other Ownership Interests - AstraZeneca (I); Biointech (I); Moderna Therapeutics (I); Sanofi (I); Sanofi (I)
 
Elisabetta Munzone
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Exact Sciences; Ipsen; MSD Oncology; Pfizer; Seagen
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Lilly; Novartis; Pfizer; Pierre Fabre; Roche
 
Giuseppe Curigliano
Leadership - ESMO; ESMO; ESMO Open; European Society of Breast Cancer Specialists (EUSOMA=
Honoraria - Ellipses Pharma
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celcuity; Daichi-Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; GlaxoSmithKline; Guardant Health; Hengrui Therapeutics; Lilly; Menarini; Merck; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen; Veracyte
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daichii Sankyo; Pfizer; Roche/Genentech
 
Ann Partridge
Patents, Royalties, Other Intellectual Property - Wolters Kluwer- royalties for authorship of UpToDate